| Autor: |
Perlman DC; a Chemical Dependency Institute, Mount Sinai Beth Israel , New York , New York , USA., Jordan AE, McKnight C, Young C, Delucchi KL, Sorensen JL, Des Jarlais DC, Masson CL |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of addictive diseases [J Addict Dis] 2014; Vol. 33 (4), pp. 322-31. |
| DOI: |
10.1080/10550887.2014.969623 |
| Abstrakt: |
Drug users are at high risk of viral Hepatitis A, B, and C. The prevalence of Hepatitis A, Hepatitis B, and Hepatitis C, associated factors, and vaccine seroconversion among drug treatment program participants in a randomized controlled trial of hepatitis care coordination were examined. Of 489 participants, 44 and 47% required Hepatitis A/Hepatitis B vaccinations, respectively; 59% were Hepatitis C positive requiring linkage to care. Factors associated with serologic statuses, and vaccine seroconversion are reported; implications for strategies in drug treatment settings are discussed. Results suggest generalizable strategies for drug treatment programs to expand viral hepatitis screening, prevention, vaccination, and linkage to care. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
